Publications by authors named "Van-Seuningen I"

Article Synopsis
  • The epidermal growth factor receptor (EGFR) family is important in cancer treatment because they are key players in many types of cancer.
  • Standard therapies like tyrosine kinase inhibitors and monoclonal antibodies improve survival but face challenges due to resistance.
  • New approaches, including inhibitory peptides, bispecific antibodies, and insights into the cell surface interactome of ErbB proteins, are emerging as potential strategies to improve treatment efficacy and overcome resistance.
View Article and Find Full Text PDF

While the transmembrane glycoprotein mucin 1 (MUC1) is clustered at the apical borders of normal epithelial cells, with transformation and loss of polarity, MUC1 is found at high levels in the cytosol and is uniformly distributed over the entire surface of carcinoma cells, where it can promote tumor progression and adversely affects the response to therapy. Clear cell renal cell carcinoma (ccRCC), the main histotype of kidney cancer, is typically highly resistant to conventional and targeted therapies for reasons that remain largely unknown. In this context, we investigated whether MUC1 also plays a pivotal role in the cellular and molecular events driving ccRCC progression and chemoresistance.

View Article and Find Full Text PDF

Background: Pancreatic adenocarcinoma (PDAC) is a devastating disease with an urgent need for therapeutic innovation. Immune checkpoint inhibition has shown promise in a variety of solid tumors, but most clinical trials have failed to demonstrate clinical efficacy in PDAC. This low efficacy is partly explained by a highly immunosuppressive microenvironment, which dampens anti-tumor immunity through the recruitment or induction of immunosuppressive cells, particularly regulatory T cells (Tregs).

View Article and Find Full Text PDF

Background: Triple-Negative Breast Cancer is particularly aggressive, and its metastasis to the brain has a significant psychological impact on patients' quality of life, in addition to reducing survival. The development of brain metastases is particularly harmful in triple-negative breast cancer (TNBC). To date, the mechanisms that induce brain metastasis in TNBC are poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers are studying how the way cells use energy changes in pancreatic neuroendocrine tumors (pNETs), which is important for understanding how tumors grow.
  • They looked at different gene data and metabolic information to see how these tumors differ from healthy cells.
  • The study found unique metabolism patterns in pNETs that might affect tumor growth and could help in finding new ways to diagnose and treat these tumors in the future.
View Article and Find Full Text PDF

Pancreatic diseases, such as pancreatitis or pancreatic ductal adenocarcinoma, are characterized by the presence of activated pancreatic stellate cells (PSCs). These cells represent key actors in the tumor stroma, as they actively participate in disease development and progression: reprograming these PSCs into a quiescent phenotype has even been proposed as a promising strategy for restoring the hallmarks of a healthy pancreas. Since TRPM7 channels have been shown to regulate hepatic stellate cells proliferation and survival, we aimed to study the role of these magnesium channels in PSC activation and proliferation.

View Article and Find Full Text PDF
Article Synopsis
  • Clear cell renal cell carcinoma (ccRCC) is a common and treatment-resistant kidney cancer characterized by abnormal lipid accumulation, with a focus on the oncogenic miRNA miR-21 and its target, PPAR-α, a key lipid metabolism regulator.
  • In a study of 52 ccRCC samples, researchers found that higher levels of miR-21 were linked to lower levels of PPAR-α, and laboratory experiments showed that boosting PPAR-α reduced miR-21 levels and affected related transcription factors, while increasing tumor suppressor genes.
  • The research highlighted a complex feedback loop between miR-21 and PPAR-α, suggesting that targeting miR-21 could be a potential therapeutic strategy to enhance P
View Article and Find Full Text PDF

The adaptability of microscale devices allows microtechnologies to be used for a wide range of applications. Biology and medicine are among those fields that, in recent decades, have applied microtechnologies to achieve new and improved functionality. However, despite their ability to achieve assay sensitivities that rival or exceed conventional standards, silicon-based microelectromechanical systems remain underutilised for biological and biomedical applications.

View Article and Find Full Text PDF

Background: Pancreatic adenocarcinoma (PDAC) is a deadly cancer with an extremely poor prognosis. MUC4 membrane-bound mucin is neoexpressed in early pancreatic neoplastic lesions and is associated with PDAC progression and chemoresistance. In cancers, microRNAs (miRNAs, small noncoding RNAs) are crucial regulators of carcinogenesis, chemotherapy response and even metastatic processes.

View Article and Find Full Text PDF
Article Synopsis
  • PRC2 is crucial for regulating gene expression tied to cellular identity during development by modifying histones.
  • A null allele in zebrafish leads to digestive organ defects, like a smaller pancreas and loss of intestinal structures, causing death by 10-12 days post-fertilization.
  • The loss of PRC2 also impacts neuronal differentiation and increases locomotor activity, establishing zebrafish as a valuable model for studying human disorders related to PRC2 dysfunction.
View Article and Find Full Text PDF

The HER2 receptor and its MUC4 mucin partner form an oncogenic complex via an extracellular region of MUC4 encompassing three EGF domains that promotes tumor progression of pancreatic cancer (PC) cells. However, the molecular mechanism of interaction remains poorly understood. Herein, we decipher at the molecular level the role and impact of the MUC4 domains in the mediation of the binding affinities with HER2 and the PC cell tumorigenicity.

View Article and Find Full Text PDF

Background Information: Although improvements have been made in the management of pancreatic adenocarcinoma (PDAC) during the past 20 years, the prognosis of this deadly disease remains poor with an overall 5-year survival under 10%. Treatment with FOLFIRINOX, a combined regimen of 5-fluorouracil, irinotecan (SN-38) and oxaliplatin, is nonetheless associated with an excellent initial tumour response and its use has allowed numerous patients to go through surgery while their tumour was initially considered unresectable. These discrepancies between initial tumour response and very low long-term survival are the consequences of rapidly acquired chemoresistance and represent a major therapeutic frontier.

View Article and Find Full Text PDF

Background: The Sd antigen and corresponding biosynthetic enzyme B4GALNT2 are primarily expressed in normal colonic mucosa and are down-regulated to a variable degree in colon cancer tissues. Although their expression profile is well studied, little is known about the underlying regulatory mechanisms.

Methods: To clarify the molecular basis of Sd expression in the human gastrointestinal tract, we investigated the transcriptional regulation of the human B4GALNT2 gene.

View Article and Find Full Text PDF

Twenty mucin genes have been identified and classified in two groups (encoding secreted and membrane-bound proteins). Secreted mucins participate in mucus formation by assembling a 3-dimensional network via oligomerization, whereas membrane-bound mucins are anchored to the outer membrane mediating extracellular interactions and cell signaling. Both groups have been associated with carcinogenesis progression in epithelial cancers, and are therefore considered as potential therapeutic targets.

View Article and Find Full Text PDF

Sepsis is the leading cause of acute kidney injury (AKI) in critical care patients. A cornerstone of sepsis-associated AKI is dysregulated inflammation driven by excessive activation of Toll-like receptor 4 (TLR4) pathway. MUC1, a membrane-bound mucin expressed in both epithelial tubular cells and renal macrophages, has been shown to be involved in the regulation of TLRs.

View Article and Find Full Text PDF

The mechanisms whereby the Hippo pathway effector YAP regulates cancer cell stemness, plasticity, and chemoresistance are not fully understood. We previously showed that in 5-fluorouracil (5-FU)-resistant colorectal cancer cells, the transcriptional coactivator YAP is differentially regulated at critical transitions connected with reversible quiescence/dormancy to promote metastasis. Here, we found that experimental YAP activation in 5-FU-sensitive and 5-FU-resistant HT29 colorectal cancer cells enhanced nuclear YAP localization and the transcript levels of the retinoic acid (RA) receptors RARα/γ and RAR target genes , and through RA Response Elements (RARE).

View Article and Find Full Text PDF
Article Synopsis
  • Magnesium (Mg) is the second most common cation in cells, but its specific functions in cell health and disease are not fully understood.
  • Mg homeostasis involves various transporters like MRS2, TRPM6/7, MAGT1, SCL41A1, and CNNM, which may influence key characteristics of cancer cells.
  • The review examines how these transporters are expressed in digestive cancers, their relationship with patient survival data, and their roles in cancer cell behavior and signaling pathways.
View Article and Find Full Text PDF

Mucins are commonly associated with pancreatic ductal adenocarcinoma (PDAC) that is a deadly disease because of the lack of early diagnosis and efficient therapies. There are 22 mucin genes encoding large -glycoproteins divided into two major subgroups: membrane-bound and secreted mucins. We investigated mucin expression and their impact on patient survival in the PDAC dataset from The Cancer Genome Atlas (PAAD-TCGA).

View Article and Find Full Text PDF

Chromatin remodeler complexes regulate gene transcription, DNA replication and DNA repair by changing both nucleosome position and post-translational modifications. The chromatin remodeler complexes are categorized into four families: the SWI/SNF, INO80/SWR1, ISWI and CHD family. In this review, we describe the subunits of these chromatin remodeler complexes, in particular, the recently identified members of the ISWI family and novelties of the CHD family.

View Article and Find Full Text PDF
Article Synopsis
  • The prognosis of colon cancer is influenced by tumor-infiltrating lymphocytes and the effectiveness of immune responses triggered by chemotherapy.
  • Research indicates that gut microbiota plays a role in determining whether intestinal epithelial cells (IECs) undergo tolerogenic or immunogenic cell death, affecting T cell accumulation in colon cancer patients and mice.
  • Specific gut microbes, like Bacteroides fragilis, enhance protective immune responses against colon cancer by promoting apoptotic IECs and activating PD-1 T cells in an interleukin-dependent manner.
View Article and Find Full Text PDF

Cellular stress response contributes to epithelial defense in adaptation to environment changes. Galectins play a pivotal role in the regulation of this response in malignant cells. However, precise underlying mechanisms are largely unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Membrane-bound mucins are large O-glycoproteins linked to various cancers and inflammatory diseases, and they can interact with the ErbB2 receptor, impacting cancer outcomes.
  • The paper highlights that mucins MUC3, MUC4, MUC12, MUC13, and MUC17 share an evolutionary origin and similar structural features, particularly EGF-like and SEA domains.
  • The study analyzes the structure-function relationships of these mucins, suggesting they have shared biological roles and discusses the potential for targeting ErbB2-related pathways in cancer therapies.
View Article and Find Full Text PDF
Article Synopsis
  • The discovery of cancer cell plasticity reveals that cancer cells can transform into cancer stem cells (CSCs), complicating treatment strategies involving chemotherapy and radiotherapy.
  • Researchers suggest that targeting the epigenetic factors that regulate CSCs could offer new therapeutic options, although current methods with certain inhibitors may not be the most effective for treating advanced solid tumors like colorectal cancer.
  • The review highlights challenges in isolating CSCs and evaluating existing epigenetic inhibitors, proposing that analyzing associations between CSC markers and chromatin modifier expression may help identify more effective treatment candidates.
View Article and Find Full Text PDF